Dental anesthesia journal flags GLP-1 agonists as preoperative blind spot
Japanese authors argue sedation teams may not be asking about incretin use despite delayed gastric emptying and aspiration concerns.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 30 20:00 ETSource: Journal of dental anesthesia and pain medicine
The wire
- 01A commentary in the Journal of Dental Anesthesia and Pain Medicine identifies GLP-1 receptor agonist use as a gap in routine preoperative assessment for dental sedation.
- 02Dental and office-based sedation providers see patients who may not volunteer incretin use, making medication history and fasting guidance a practical screening issue.
- 03The piece is a perspective in a specialty journal rather than a guideline or outcomes study; it does not establish event rates in dental sedation.
From the source
Read at pubmed.ncbi.nlm.nih.govGLP-1 receptor agonists and dental sedation: a potential blind spot in preoperative assessment
Journal of dental anesthesia and pain medicine · 2026 Oct · Yamamoto T, Kishimoto N et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42889474/
